Effectiveness of Fatigue and Activity Management in Work (FAME-W) for Individuals With Inflammatory Arthritis (FAME-W)

November 18, 2021 updated by: Deirdre Connolly, University of Dublin, Trinity College

Testing the Effectiveness of Fatigue and Activity Management in Work (FAME-W) Self-management Intervention for Individuals With Inflammatory Arthritis

Many individuals with Inflammatory Arthritis (IA) experience symptoms of pain and fatigue which interfere with work. Over 50% of people with IA report workplace difficulties resulting in sick leave, absenteeism and reduced productivity. Loss of ability to continue paid employment results in physical, emotional and financial hardship for individuals with IA and has societal and economic implications. Previous research has identified pain and fatigue as dominant symptoms that interfere with work capacity and therefore interventions are required to reduce the impact of these symptoms on work activities. The purpose of this study therefore is to test the effectiveness of a 4-week Fatigue and Activity Management Education for Work intervention. The study will use a mixed methods design. A randomized control trial will test the effectiveness of the intervention and a qualitative process evaluation with explore acceptability and participants' experiences of the intervention. Individuals with IA, of working age, will be recruited in Rheumatology outpatient departments of three hospitals. Study participants will be randomly assigned to a four-week online self-management intervention or a self-guided symptom management workbook. Study measures consist of self-report questionnaires related to work and symptom management. All participants will also be invited to an interview to discuss their experience of participating in the study.

Study Overview

Detailed Description

Rheumatic diseases (RD) include over 100 different types of arthritis, the most frequently occurring being Rheumatoid Arthritis, Osteoarthritis, Scleroderma, Systemic Lupus erythmatosus and ankylsoing Spondylitis. However, Inflammatory Arthritis (IA) are one of the most common causes of work disability and despite improvements in medical management of IA, up to 50% of people with IA report workplace difficulties resulting in sick leave, absenteeism and reduced productivity.

This study builds on existing research investigating the impact of IA on work performance of individuals. These earlier studies examined how symptoms of fatigue, pain and stress impact on work capacity of individuals with IA. Based on the findings of these studies a self-management program, FAtigue Management Education for Work (FAME-W) was designed to reduce the impact of fatigue, pain and stress on work performance of individuals with IA. Pilot testing of FAME-W, with a non-experimental design, showed improvements in fatigue, work performance, pain and mood following participation in FAME-W. The proposed study will build on this research by testing the effectiveness of FAME-W as a work-focused self-management intervention to increase work performance of individuals with IA.

Project Design and Methodology

Study Aim

The purpose of this study is to test the effectiveness and acceptability of FAME-W to manage the physical, mental and social demands of work of individuals with IA.

Study Objectives

  • To test the effectiveness of FAME-W in reducing the impact of fatigue, pain and stress on work performance of individuals with Inflammatory Arthritis.
  • To test the effectiveness of FAME-W in improving work ability of individuals with Inflammatory Arthritis
  • To explore the acceptability of FAME-W as a work-based self-management intervention for individuals with Inflammatory Arthritis

Study Design

The study methodology will follow the United Kingdom Medical Research Council (MRC) framework for evaluating complex interventions. A complex intervention consists of a number of interacting components such as those included in the FAME-W intervention. The MRC framework recommends collecting quantitative and qualitative data when evaluating complex interventions. This study will therefore use a sequential exploratory mixed methods design.

The quantitative phase will be a pragmatic randomized control trial (RCT) to test the effectiveness of FAME-W as a work focused self-management intervention to improve individuals' ability to manage their work demands. The CONSORT guidelines for the design and reporting of RCTs will be used at all stages from recruitment, randomization, data collection, analysis and reporting. For the purposes of the proposed study, participants will be randomly allocated to either the group based FAME-W intervention or to a handbook only group. Participants randomized to the group-based FAME-W group will attend an online four-week FAME-W program. The participants in handbook only group will be given a self-guided FAME-W handbook.

The qualitative phase will use a Qualitative Descriptive (QD) design to explore participants' experiences and acceptability of FAME-W. QD is frequently used in health research to evaluate the acceptability and sustainability of health-related interventions. It is considered an appropriate methodology for needs assessments and for informing the planning and delivery of clinical interventions.

Sample Size

Based on the previous studies the individual scores for Work Role Functioning (WRF) questionnaire this study is powered for an effect size of 0.7. To detect an 0.7, 100 participants are required (50 for the group intervention and 50 for handbook only group) to show significance at 5% level, 80% power. Participants will be recruited in groups of 12-14 and then allocated to the intervention or control group using random allocation software.

Data collection methods

Quantitative Data:

Patient Reported Outcome Measures (PROMS, outlined below) will be used to collect quantitative data

Qualitative phase: Qualitative data will be collected from individual interviews and focus groups.

Data collection will be carried out immediately before FAME-W commences, immediately following completion of FAME-W, and 3 months following completion of the program.

Data analysis Quantitative data: Baseline characteristics will be analyzed using descriptive statistics. Multilevel linear regression will be used to examine differences between groups for the primary and secondary outcome measures. Statistical significance at p<0.05 will be assumed throughout.

Qualitative data: Semi-structured interviews will be audio-taped and transcribed. Data analysis will be guided by Braun and Clarke's seven stage thematic analysis of qualitative data.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Deirdre Connolly, PhD
  • Phone Number: +35318963216
  • Email: connoldm@tcd.ie

Study Locations

    • Leinster
      • Dublin, Leinster, Ireland, D08 EF20
        • Recruiting
        • Trinity College Dublin
        • Contact:
          • Deirdre Connolly, PhD
          • Phone Number: 3216 +35318963216
          • Email: connoldm@tcd.ie
        • Contact:
          • Shalaleh Karkon, MSc
          • Phone Number: +35318963216
          • Email: karkons@tcd.ie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Inflammatory Arthritis,
  • In full-time or part-time employment
  • Must be able to provide informed consent,
  • Must be able to participate in a four-week group-based self-management intervention
  • Must have access to an electronic device and stable internet access

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: FAME-W intervention
Four-week self-management education programme
FAME-W is an occupational therapy led, four-week group based self-management intervention. It focuses on providing people with IA skills and confidence to manage demands of their employment and daily life through education on IA, self-management techniques, managing symptoms of fatigue, pain and stress and managing physical and mental health.
Active Comparator: Arm 2: FAME-W handbook
Self-guided FAME-W handbook
Individuals in this arm receive a self-guided FAME-W handbook containing the same information as that covered in the four week FAME-W program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work Role Functioning Questionnaire
Time Frame: Three months
Work Role Functioning questionnaire is a 27-self-report questionnaire that measures an individual's ability to meet demands of five categories of work: scheduling, output, psychical, mental and social demands. All 27 items are scored on a five point scale, with a score of four given for the response 'difficult none of the time' and a score of zero representing 'difficult all of the time'. Each of the five sub-scales are scored separately. A score is established by adding the response of each item, calculating the average and multiplying this by 25 to achieve an overall percentage. The overall percent can range from 0% (difficult all of the time), to 100% (never difficult) meeting the demands of the job.
Three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Euro QoL 5 Dimensions -5 levels (5D-5L)
Time Frame: Three months
Euro QoL 5 Dimensions -5 levels scale evaluates the health-related quality of life and compromises two components: a health descriptive component and a visual analog scale (VAS) . It has five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each category is scored from 1 (no problem) to 5 (extreme problems). Scores range from 1-25. Higher scores represent higher levels of difficulty. A visual analogue scale measures self-perception of health-related quality of life on a scale of 0-100. Higher scores represent better levels of health-related quality of life.
Three months
Multidimensional Fatigue Inventory
Time Frame: Three months
Multidimensional Fatigue Inventory evaluates five dimensions of fatigue: general fatigue, physical fatigue, reduced motivation, reduced activity, and mental fatigue. It is a 20-item self-report questionnaire scored from 4 to 20. Higher scores indicate higher levels of fatigue
Three months
Arthritis Work Spillover
Time Frame: Three months
Arthritis Work Spillover is designed to assess the extent to which the demands of arthritis interfere with work performance and the extent to which work interferes with managing arthritis. Items are scored on a 5-point Likert scale where 1= strongly disagree and 5 = strongly agree. Scores range from 6 - 30. Higher scores indicate higher level of interference between work and arthritis
Three months
Hospital Anxiety and Depression scale (HADS)
Time Frame: Three months
This scale is a self-report measure with two sub scales for measuring anxiety and depression. Each scale contains seven items and ranges from a score of 0 to 21. Higher scores indicate higher levels of anxiety and depression.
Three months
The Stanford Arthritis Self-Efficacy Scale Short Form
Time Frame: Three months
The Stanford Arthritis Self-Efficacy Scale Short Form is a self-administered, 20-item disease-specific questionnaire suitable for all types of arthritis. It consists of three sub scales: physical function, other symptoms, and pain.Each item is scored between one (very uncertain) and 10 (very certain) with higher scores indicating higher levels of self-efficacy.
Three months
The Arthritis Impact Measurement Scale
Time Frame: Three months
The Arthritis Impact Measurement Scale was developed to measure the physical, mental, and emotional well-being of individuals with arthritis. It consists of five domains: physical functioning, symptoms, mood/affect, social interaction, and work-role components. Scores range from 0-10. Higher scores indicate poorer overall health.
Three months
The Short Form McGill Pain Questionnaire
Time Frame: Three months
The Short Form McGill Pain Questionnaire was developed to measure pain in adults with chronic pain, including individuals with rheumatic conditions. Scores range from zero to 10 with higher scores indicating higher levels of pain intensity
Three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Deirdre Connolly, PhD, University of Dublin, Trinity College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2021

Primary Completion (Anticipated)

September 30, 2022

Study Completion (Anticipated)

September 30, 2023

Study Registration Dates

First Submitted

November 2, 2021

First Submitted That Met QC Criteria

November 18, 2021

First Posted (Actual)

December 1, 2021

Study Record Updates

Last Update Posted (Actual)

December 1, 2021

Last Update Submitted That Met QC Criteria

November 18, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UDublinOT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized individual participant data may be shared for results presented in publications of quantitative data on request to the study contact person.

IPD Sharing Time Frame

Data will be available for six months following related publications

IPD Sharing Access Criteria

Requests for data sharing can be made to the study central contact person via email.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Arthritis

Clinical Trials on FAME-W self-management intervention

3
Subscribe